Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-5-7
|
pubmed:abstractText |
CTLA-4 has been proposed to negatively regulate immune responses, and mice deficient for CTLA-4 expression succumb to a lymphoproliferative disorder within a few weeks after birth. This study assessed the responsiveness of CTLA-4-deficient T cells expressing a class I-restricted TCR specific for lymphocytic choriomeningitis virus (LCMV). The kinetics of T cell proliferation were studied in vitro after stimulation of T cells with full and partial T cell agonists. No gross abnormalities in CTLA-4-deficient T cells could be detected. Using adoptive transfer experiments, T cell responses were also measured in vivo after infection with LCMV. Low dose infection with LCMV leads to strong expansion of specific T cells followed by a reduction in T cells that parallels the elimination of Ag. The kinetics of T cell expansion and elimination after low dose LCMV infection were not affected by the absence of CTLA-4. High dose infection of mice with LCMV leads to a transient expansion of T cells followed by T cell exhaustion, where all specific T cells are eliminated. T cell exhaustion also occurred in the absence of CTLA-4. Thus, surprisingly, the absence of CTLA-4 did not interfere with T cell activation, down-regulation of ongoing T cell responses after the elimination of Ag, or the exhaustion of T cell responses in the presence of excessive amounts of Ag.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation,
http://linkedlifedata.com/resource/pubmed/chemical/CTLA-4 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Ctla4 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoconjugates,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/abatacept
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
160
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
95-100
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9551960-Amino Acid Sequence,
pubmed-meshheading:9551960-Animals,
pubmed-meshheading:9551960-Antigens, CD,
pubmed-meshheading:9551960-Antigens, Differentiation,
pubmed-meshheading:9551960-CD8-Positive T-Lymphocytes,
pubmed-meshheading:9551960-CTLA-4 Antigen,
pubmed-meshheading:9551960-Immunoconjugates,
pubmed-meshheading:9551960-Lymphocytic Choriomeningitis,
pubmed-meshheading:9551960-Mice,
pubmed-meshheading:9551960-Mice, Knockout,
pubmed-meshheading:9551960-Mice, Transgenic,
pubmed-meshheading:9551960-Peptides,
pubmed-meshheading:9551960-T-Lymphocytes, Cytotoxic
|
pubmed:year |
1998
|
pubmed:articleTitle |
Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells.
|
pubmed:affiliation |
Department of Medical Biophysics, Ontario Cancer Institute, Toronto, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|